China sanctions pharmaceutical company for RPM over contraceptives
China’s State Administration for Market Regulation has fined a pharmaceutical company €1.7 million for fixing the resale price of two widely-used emergency contraceptives for six years.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.